{
    "root": "8a49fbcb-9ae0-4aa1-bf59-e1d4420ffc56",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Dicyclomine Hydrochloride",
    "value": "20250319",
    "ingredients": [
        {
            "name": "DICYCLOMINE HYDROCHLORIDE",
            "code": "CQ903KQA31"
        },
        {
            "name": "D&C RED NO. 28",
            "code": "767IP0Y5NH"
        },
        {
            "name": "FD&C BLUE NO. 1",
            "code": "H3R47K3TBD"
        },
        {
            "name": "FD&C RED NO. 40",
            "code": "WZB9127XOA"
        },
        {
            "name": "GELATIN, UNSPECIFIED",
            "code": "2G86QN327L"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4"
        },
        {
            "name": "SODIUM LAURYL SULFATE",
            "code": "368GB5141J"
        }
    ],
    "indications": "dicyclomine hydrochloride indicated treatment patients functional bowel/irritable bowel syndrome .",
    "contraindications": "must adjusted individual patient needs .",
    "warningsAndPrecautions": "dicyclomine hydrochloride capsules , usp 10 mg capsules : size 4 hard gelatin capsules , dark blue clear cap body . rectified axial imprinted white ink watson 794 cap 10 mg body , bottles ; bottle 20 68788-9705-2 bottle 30 - 68788-9705-3 bottle 60 - 68788-9705-6 bottle 100 - 68788-9705-1 store 20\u00b0 25\u00b0c ( 68\u00b0 77\u00b0f ) [ usp controlled room temperature ] . keep reach children . dispense well-closed container defined usp/nf .",
    "adverseReactions": "dicyclomine hydrochloride contraindicated infants less 6 months age [ ( ) ] , nursing mothers [ ( ) ] , patients : \u2022unstable cardiovascular status acute hemorrhage \u2022myasthenia gravis [ ( ) ] \u2022glaucoma [ ( ) ( ) ] \u2022obstructive uropathy [ ( ) ] \u2022obstructive disease gastrointestinal tract [ ( ) ] \u2022severe ulcerative colitis [ ( ) ] \u2022reflux esophagitis",
    "indications_original": "Dicyclomine hydrochloride is indicated for the treatment of patients with functional bowel/irritable bowel syndrome.",
    "contraindications_original": "Dosage must be adjusted to individual patient needs.",
    "warningsAndPrecautions_original": "Dicyclomine Hydrochloride Capsules, USP \n                  \n                  10 mg capsules: Size 4 hard gelatin capsules, with dark blue clear cap and body. Rectified axial imprinted with white ink WATSON over 794 on cap and 10 mg on the body, in bottles of;\n                  Bottle of 20 68788-9705-2\n                  Bottle of 30 - 68788-9705-3\n                  Bottle of 60 - 68788-9705-6\n                  Bottle of 100 - 68788-9705-1\n                  Store at 20\u00b0 to 25\u00b0C (68\u00b0 to 77\u00b0F) [see USP controlled room temperature].\n                  Keep out of the reach of children. \n                  Dispense in a well-closed container as defined in the USP/NF.",
    "adverseReactions_original": "Dicyclomine hydrochloride is contraindicated in infants less than 6 months of age [see\u00a0Use in Specific Populations ()], nursing mothers [see\u00a0Use in Specific Populations ()], and in patients with: \n                  \n                     \n                        \u2022unstable cardiovascular status in acute hemorrhage\n                     \n                        \u2022myasthenia gravis [see\u00a0Warnings and Precautions (\n                        )]\n                     \n                     \n                        \u2022glaucoma [see\u00a0Adverse Reactions () and\u00a0Drug Interactions\u00a0()]\n                     \n                     \n                        \u2022obstructive uropathy [see\u00a0Warnings and Precautions (\n                        )]\n                     \n                     \n                        \u2022obstructive disease of the gastrointestinal tract [see\u00a0Warnings and Precautions (\n                        )]\n                     \n                     \n                        \u2022severe ulcerative colitis [see\u00a0Warnings and Precautions (\n                        )]\n                     \n                     \n                        \u2022reflux esophagitis"
}